The mutation of the ob gene is known to induce a phenotype of obesity accompanied by symptoms including enhanced production of glucocorticoid. Chronic administration to ob/ob mice of leptin, the ob gene product, reverses hypercorticosteronemia. This establishes a clear relation between adipocyte and hypothalamo-pituitary-adrenal (HPA) axis functions. In the present study we investigated the acute modulatory effects of food intake-stimulated leptin secretion on HPA axis activity and hypothalamic leptin receptor (Ob-Rb) expression in 24-hour fasting, adult female, BALB/c mice after insulin-induced hypoglycemia. Our results indicate that: (1) food supply for 45 min to 24-hour fasting mice increased plasma glucose levels and reversed both hypercorticosteronemia and hypoleptinemia; (2) the insulin-induced hypoglycemia produced a marked HPA axis activation in animals with no access to food but this response was fully prevented by food intake and the consecutive increase in plasma leptin levels; (3) the inhibitory effect of leptin on the HPA axis response to insulin-induced hypoglycemia was corroborated by i.p. administration of murine leptin, and (4) fasting-induced hypothalamic Ob-Rb overexpression is not modulated by insulin itself but by leptin, since increase in leptin levels by food intake or by administration of exogenous leptin completely reversed this Ob-Rb overexpression. These results confirm the inhibitory effect of leptin on the HPA axis response to various stress stimuli. They clearly demonstrate that acute food intake in 24-hour fasting mice: (a) rapidly reduced fasting-induced hypercorticosteronemia by enhancing both spontaneous and insulin-elicited endogenous leptin secretion; (b) fully prevented HPA axis response to insulin administration, by rapidly increasing endogenous leptin secretion and probably also by diminishing the extent and the duration of insulin-induced hypoglycemia, and (c) abolished hypothalamic Ob-Rb overexpression induced by fasting itself combined with insulin treatment. The present data strongly suggests an inhibitory effect of endogenous leptin on insulin-induced HPA axis response, an interaction relevant to the physiological adaptation to starvation and caloric excess, and further supports the pivotal role played by the hypothalamus in restoring homeostasis in different allostatic states.

1.
McEwen BS: Stress, adaptation, and disease. Allostasis and allostatic load. Ann NY Acad Sci 1998;840:33–44.
2.
Woods SC, Seeley RJ, Porte D Jr, Schwartz MW: Signals that regulate food intake and energy homeostasis. Science 1998;280:1378–1382.
3.
Schwartz MW, Seeley RL, Campfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101–1106.
4.
Hamann A, Matthaei S: Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 1996;104:293–300.
5.
Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632–635.
6.
Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV: Localization of leptin receptor in the human brain. Neuroendocrinology 1997;66:145–150.
7.
Costa A, Poma A, Martignoni E, Nappi G, Ur E, Grossman A: Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. Neuroreport 1997;8:1131–1134.
8.
Yamamoto S, Morimoto I, Kai K, Arao t, Fujihira T, Morita E, Kannan H, Eto S: Centrally administered murine leptin stimulates plasma arginine-vasopressin secretion and increases the level of mRNA expression in the supraoptic nucleus of conscious rats. Neuroendocrinology 1999;70:207–212.
9.
Huang Q, Rivest R, Richard D: Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 1998;139:1524–1532.
10.
Jin L, Burguera BG, Couce ME, Scheithauer BW, Lamsan J, Eberhardt NL, Kulig E, Lloyd RV: Leptin and leptin receptor expression in normal and neoplastic human pituitary: Evidence of a regulatory role of leptin on pituitary cell proliferation. J Clin Endocrinol Metab 1999;84:2903–2911.
11.
Chavez RA, Moore HP: Targeting of leptin to the regulated secretory pathway in pituitary AtT-20 cells. Curr Biol 1997;7:349–352.
12.
Malendowicz LK, Macchi C, Nussdorfer GG, Nowak KW: Acute effects of recombinant murine leptin on rat pituitary-adrenocortical function. Endocr Res 1998;24:235–246.
13.
Pralong FP, Roduit R, Waeber G, Castillo E, Mosimann F, Thorens B, Gaillard RC: Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland. Endocrinology 1998;139:4264–4268.
14.
Stephens TW, Basinski M, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffman H, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR Jr, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in the antiobesity action of obese gene product. Nature 1995;377:530–532.
15.
Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250–252.
16.
Spinedi E, Gaillard RC: A regulatory loop between the hypothalamo-pituitary-adrenal axis and circulating leptin: A physiological role of ACTH. Endocrinology 1998;139:4016–4020.
17.
Murakami T, Iida M, Shima K: Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 1995;214:1260–1267.
18.
Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW: Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271:5301–5304.
19.
Daneva T, Spinedi E, Hadid R, Gaillard RC: Impaired hypothalamo-pituitary-adrenal axis function in Swiss nude athymic mice. Neuroendocrinology 1995;62:79–86.
20.
Kaneko M, Hiroshige T, Shinsako J, Dallman MF: Diurnal changes in amplification of hormone rhythms in the adrenocortical system. Am J Physiol 1980;2398:R309–R316.
21.
Spinedi E, Giacomini M, Jacquier MC, Gaillard RC: Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: Evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 1991;53:160–170.
22.
Chisari A, Spinedi E, Voirol MJ, Giovambattista A, Gaillard RC: A phospholipase A2-related snake venom (from Crotalus durissus terrificus) stimulates neuroendocrine and immune functions: Determination of different sites of action. Endocrinology 1998;139:617–625.
23.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–179.
24.
Hoggard N, Mercer JG, Vernon Rayner D, Moar K, Trayhurn P, Williams LM: Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun 1997;232:383–387.
25.
Zar JH: Biostatistical Analysis. Englewood Cliffs, Prentice-Hall, 1974.
26.
Akana SF, Dallman MF, Bradbury MJ, Scribner KA, Strack AM, Walker CD: Feedback and facilitation in the adrenocortical system: Unmasking facilitation by partial inhibition of the glucocorticoid response to prior stress. Endocrinology 1992;131:57–68.
27.
Chowers I, Einat R, Feldman S: Effects of starvation on levels of corticotrophin releasing factor, corticotrophin and plasma corticosterone in rats. Acta Endocrinol (Copenh) 1969;61:687–694.
28.
Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997;138:3859–3863.
29.
Larsson H, Ahren B: Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996;81:4428–4432.
30.
Xu B, Kalra PS, Farmerie WG, Kalra SP: Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: Effects of food restriction. Endocrinology 1999;140:2868–2875.
31.
Ahima RS, Prabakaran D, Flier J: Postnatal leptin surge and regulation of circadian rhythm by feeding: Implication for energy homeostasis and neuroendocrine function. J Clin Invest 1998;101:1020–1027.
32.
Hardie LJ, Vernon Rayner D, Holmes S, Trayhurn P: Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 1996;223:660–665.
33.
Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527–529.
34.
Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 1995;44:1467–1470.
35.
Karteszi M, Dallman MF, Makara GB, Stark E: Regulation of the adrenocortical response to insulin-induced hypoglycemia. Endocrinology 1982;111:535–541.
36.
Plotsky PM, Bruhn TO, Vale W: Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 1985;117:323–329.
37.
Nye EJ, Bornstein SR, Grice JE, Tauchnitz R, Hockings GI, Strakosch CR, Jackson RV, Torpy DJ: Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans. J Neuroendocrinol 2000;12:141–145.
38.
De Vos P, Saladin R, Auwerx J, Staels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958–15961.
39.
Chautard T, Spinedi E, Voirol MJ, Pralong FP, Gaillard RC: Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administration. Neuroendocrinology 1999;69:360–369.
40.
Tartaglia LA, Dembski M, Wenig X, Deng N, Culpepper J, De Vos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression of a leptin receptor, OB-R. Cell 1995;83:1263–1271.
41.
Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P: Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996;387:113–116.
42.
Huang XF, Lin S, Zhang R: Upregulation of leptin receptor mRNA expression in obese mouse brain. Neuroreport 1997;8:1035–1038.
43.
Herman JP, Patel PD, Akil H, Watson SJ: Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol 1989;3:1886–1894.
44.
Dallman MF, Akana SF, Bhatnagar S, Bell ME, Choi SJ, Chu A, Horsley C, Levin N, Meijer O, Soriano LR, Strack AM, Viau V: Starvation: early signals, sensors, and sequelae. Endocrinology 1999;140:4015–4023.
45.
Viau V, Sharma S, Plotsky PM, Meaney JM: Increased plasma ACTH response to stress in nonhandled compared with handled rats require basal levels of corticosterone and are associated with increased levels of ACTH secretagogues in the median eminence. J Neurosci 1993;13:1097–1105.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.